Purchase Order 75D30124P19811
- Not listed
- This is a federal purchase order contract awarded to Inotiv, Inc., a contract research organization, by the Centers for Disease Control and Prevention (CDC) for a pathology study. The contract has a ceiling value of $17,550.00 and is a firm-fixed-price contract with a performance period ending on December 31, 2024. The contract does not have a set-aside designation, indicating that Inotiv competed for this opportunity in the open market. Inotiv is a for-profit organization and manufacturer of...
- The U.S. Centers for Disease Control and Prevention (CDC) awarded a $35,860.00 firm fixed price purchase order contract to Inotiv, Inc., a for-profit contract research organization, for the pathology evaluation of mice lungs. The contract has an ultimate completion date of April 22, 2025 and was awarded on June 11, 2024. It is not a set-aside contract. Inotiv, Inc. is a well-established company that provides a wide range of scientific research and testing services to federal agencies,...
- The Centers for Disease Control and Prevention (CDC) awarded a $6,723 purchase order to Inotiv, Inc. for pathology evaluation services. Under this firm fixed price contract, Inotiv will provide unspecified pathology evaluation services to the CDC from its facility in Morgantown, West Virginia between July 2023 and July 2024. As the prime contractor, Inotiv will perform the contracted services without the use of major subcontractors. No set aside designation or associated multi-award contract...
- This is a firm fixed-price purchase order contract awarded by the U.S. Army Medical Command (MEDCOM) to Inotiv, Inc., a for-profit contract research organization, for the provision of CULEX NXT Large Volume Blood sampling systems. The contract, valued at $374,993.07, was set aside for small businesses. Inotiv, registered with the government since 2002, has expertise in providing a range of preclinical and clinical research services to government agencies and the pharmaceutical industry. The...
- This is a $12,000 firm fixed-price purchase order contract awarded by the U.S. Environmental Protection Agency's (EPA) Office of Research and Development to Inotiv, Inc., a contract research organization. The contract is for non-GLP (non-Good Laboratory Practice) 3-strain Ames assay services, which are likely screening tests related to the analysis of burn pit smoke sample extracts. The original pre-solicitation notice indicated the EPA was seeking a sole-source contract for these specialized...
- This contract award to Inotiv, Inc. was made by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services. The $22,650 firm fixed price purchase order is for a "Ternary Gradient Analyzing System for UBORE MF-483EP-110000," which appears to be a specialized piece of analytical equipment for biomedical research. The award does not indicate any set-aside designation, suggesting Inotiv competed for this...
- This federal contract award, valued at $239,719.00, was issued by the Centers for Disease Control and Prevention (CDC) to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI), a non-profit contract research organization. The contract is for the study of radionuclides in animal urine and is a definitive, firm-fixed-price contract with a completion date of March 31, 2017. There is no set-aside designation for this award. LBERI, doing business as the Inhalation Toxicology Research...
- Inotiv Inc., doing business as BASi Research Products Division, has been awarded a $12,000 firm fixed price purchase order by the Environmental Protection Agency Office of Research and Development to provide non-GLP Ames assay services. The place of performance will be in West Lafayette, Indiana and the period of performance is expected to conclude on February 18, 2025. As a manufacturer of goods and provider of drug discovery and development services to the global pharmaceutical industry,...
- This is a $897,471 firm-fixed-price delivery order contract awarded by the Food and Drug Administration (FDA) to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI), doing business as Inhalation Toxicology Research Institute. The contract is part of a larger In Vivo Toxicology of Tobacco 2015-2020 indefinite-delivery, indefinite-quantity (IDIQ) contract vehicle. LBERI, a non-profit contract research organization, will provide preclinical research services to support the...
- This federal contract award, valued at $805,808.62, was issued by the U.S. Army Medical Command (MEDCOM) to Envigo Global Services Inc., a subsidiary of Inotiv, Inc. The contract is for non-personal support services and does not have a set-aside designation. Envigo has provided a wide range of goods and services to federal agencies, including the supply of non-human primates and associated services like testing, transportation, housing, and husbandry. This contract is likely part of Envigo's...
This federal contract award, valued at $22,830.00, was issued by the Centers for Disease Control and Prevention (CDC) to Inotiv, Inc., a for-profit contract research organization and manufacturer of goods specializing in biomedical research, drug discovery, and development services. The contract is for LAB SERVICES and is a firm fixed-price purchase order with no set-aside designation. Inotiv has extensive experience providing diverse services to federal agencies, including mammalian oral exposure studies, non-human primate acquisition and housing, pathology evaluations, laboratory services, and specialized screening tests. The company has also received multiple federal grants for advanced biomedical research initiatives. This contract award is part of Inotiv's larger Indefinite Delivery Contract (IDC) with the Environmental Protection Agency's Office of Research and Development, a $7.8 million small business set-aside contract focused on supporting the EPA's Center for Computational Toxicology and Exposure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Terminate for Convenience | $0 | 5/15/25 | |
| Not listed | Not listed | $22.8k | 8/19/24 |